PATENT CLAIM ANALYSIS

Application Number: 16026421
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "252100"]

Abstract:
A method of treating cancer in a subject includes administering to the subject a therapeutically effective amount of a small molecule agonist of EphA2 receptor protein, the small molecule having a general formula: A-L-X-Z (I).

Claim (Index 6):
The method of  claim 1 , the small molecule agonist of EphA2 receptor protein having the formula: wherein R 2  is selected from an acetyl or methyl.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 95.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15237494', '13461098', '11577770', '12373574', '10652407']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8015134833030749
- 35 USC 102 Novelty (BERT): 0.5509212226368503
- Combined Prediction Score: 0.7764542572364524
- Mean Citation Score: 376.017902
- Max Citation Score: 428.74655
- Similarity Product: 297.9631071273059

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test